HCV-IN-31
CAS No. 1998705-62-6
HCV-IN-31( —— )
Catalog No. M28773 CAS No. 1998705-62-6
HCV-IN-31 is a HCV inhibitor with an EC50/EC95 of 15.7 μM.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 102 | Get Quote |
|
| 10MG | 160 | Get Quote |
|
| 25MG | 327 | Get Quote |
|
| 50MG | 520 | Get Quote |
|
| 100MG | 750 | Get Quote |
|
| 200MG | Get Quote | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameHCV-IN-31
-
NoteResearch use only, not for human use.
-
Brief DescriptionHCV-IN-31 is a HCV inhibitor with an EC50/EC95 of 15.7 μM.
-
DescriptionHCV-IN-31 is a HCV inhibitor with an EC50/EC95 of 15.7 μM.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayMicrobiology/Virology
-
TargetHCV
-
RecptorPhospholipase
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1998705-62-6
-
Formula Weight312.3
-
Molecular FormulaC12H17FN6O3
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 60 mg/mL (192.12 mM)
-
SMILESC[C@@]1([C@H](n2c3nc(N)nc(NC)c3nc2)O[C@H](CO)[C@H]1O)F
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Riendeau D, et al. Arachidonyl trifluoromethyl ketone, a potent inhibitor of 85-kDa phospholipase A2, blocks production of arachidonate and 12-hydroxyeicosatetraenoic acid by calcium ionophore-challenged platelets. J Biol Chem. 1994;269(22):15619-15624.
molnova catalog
related products
-
Letermovir
Letermovir (AIC246) is a novel anti-CMV compound (EC50: about 5 nM in fibroblast cells). It targets the pUL56 subunit of the viral terminase complex.
-
GSK-2336805
GSK-2336805 (JNJ-56914845) is a novel potent HCV NS5A inhibitor with multigenotype activity.
-
VX-222
A potent and selective, nonnucleoside inhibitor of HCV NS5B polymerase inhibitor with Kd of 17 nM.
Cart
sales@molnova.com